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Abstract Cystic fibrosis (CF) is a single-gene disease caused by 
mutations in the CFTR gene, which result in disrupted chloride 
secretions with inspissated mucous secretions by exocrine glands. 
Nick-end labelling was used to assess DNA fragmentation in 14 
CF and 24 control duodenal samples, and in two CF and two 
control lung tissues. In CF small intestine median 46% (range: 
30-82) villus enterocytes show DNA fragmentation (vs. 3% 
(range: 1-7) in controls P< 0.001) and median 37.5% (range: 
23-79) crypt enterocytes show Ki67 antigen (/»< 0.001). In CF 
airways 57% (range: 54-70) of epithelial cells show DNA 
fragmentation. Inappropriate high DNA fragmentation is a 
feature of various CF epithelia. This could have great impact in 
understanding the mechanisms leading to disease. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Cystic fibrosis (CF) is a single-gene disease and is the most 
common, lethal, inherited disease in Caucasians, with an in-
cidence of 1 in 2000-3000 births. 
C F is caused by mutat ions in the cystic fibrosis transmem-
brane conductance regulator (CFTR) gene, which result in its 
altered expression and function [1]. Defective electrolyte trans-
port, particularly defective chloride (Cl~) transport , is the 
hallmark abnormality in C F epithelia. This disrupted epithe-
lial Cl~ secretion, which is critical for the production of prop-
erly hydrated secretions, has as a consequence that many exo-
crine organs become clogged with thick, inspissated 
secretions. In the lung the unusually viscous nature of the 
secretions is associated with chronic infections, airway ob-
struction, and eventually respiratory failure. In the gastroin-
testinal tract, obstruction of pancreatic ducts by hyperconcen-
trated secretions results in destruction of the pancreas and 
insufficient delivery of pancreatic enzymes. 
Although it has been demonstrated that C F T R is a Cl~ 
channel [2], it has been postulated that C F T R may influence 
other cellular functions. Numerous phenotypic abnormalities 
have been observed in C F epithelia, including increased elec-
trogenic Na+ absorption [3], increased sulfation of glycocon-
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jugates [4], abnormal regulation of outwardly rectifying Cl~ 
channels [5], overexpression of annexin V [6], and impaired 
cell volume regulation in intestinal crypt epithelia [7]. It is not 
currently understood how these multiple phenotypic abnor-
malities could be controlled by a defect in a Cl~ channel, 
and, thus, additional functions of C F T R have been proposed. 
Several studies have suggested that C F T R may affect the en-
docytosis and exocytosis of membrane vesicles and that 
C F T R may play a role in controlling membrane recycling 
[8]. Recently it has been reported that C F T R may participate 
in the apoptotic process by influencing the intracellular p H 
[9]. 
In this paper we demonstrate that inappropriate D N A frag-
mentat ion is a feature of C F epithelia never described before, 
thus indicating that mechanisms other than those involved in 
determining inspissated secretions of exocrine glands may be 
involved in the pathogenesis of C F . 
2. Materials and methods 
2.1. Patients 
Fourteen patients (8 male, 6 female; mean age: 11.3; range: 3-23 
years) (Table 1) affected by CF underwent duodenal endoscopy for 
diagnostic purposes. Two patients (cases #1 and #6) carried the 
AF508/AF508 mutation, 10 carried AF508/other, and two (cases #12 
and #14) carried other/other (Table 1). 
All but two patients received pancreatic enzyme supplementation 
(1000 U lipase/g fat) at the time of biopsy; 11 of them showed mild to 
moderate pulmonary disease with Pseudomonas infection. Nine of 14 
patients underwent gastric and/or duodenal biopsies because of recur-
rent vomiting, and 5 of them showed increased serum levels of anti-
gliadin IgA antibodies. Only one patient (case #14, Table 1) showed 
severe chronic diarrhoea. In two patients (cases #10 and #11, Table 1) 
intestinal biopsy was performed before diagnosis of CF because of 
failure to grow. One patient (case #5, Table 1) received a second 
biopsy 15 days after withdrawal of pancreatic enzyme, and another 
(case #14, Table 1) received a second biopsy after 3 months of ele-
mental diet because of severe chronic diarrhoea. 
Two patients (1 male, 24 years old; 1 female, 17 years old) under-
went pulmonary lobectomy because of lobar atelectasia. Both carried 
AF508/other mutation and had severe respiratory disease with recur-
rent pulmonary infections. 
Twenty subjects (8 male, 12 female; mean age: 16.4 years; range: 
3^12 years) suffering from oesophagitis (n = 9), gastritis (n = 3) and 
chronic non-specific diarrhoea (n = 8), were used as non-CF controls. 
Four non-CF patients with chronic pancreatitis and exocrine pan-
creatic insufficiency (2 male, 2 female ; mean age : 27 years ; range : 16-
35 years) were also investigated. 
Two subjects (2 male; aged 63 and 57 years) underwent pulmonary 
lobectomy because of bronchial cancer. 
Informed consent was obtained from all patients. 
2.2. Intestinal tissues 
Intestinal specimens were obtained at the duodenal-jejunal flexure 
by peroral biopsy from all patients. Immediately after expiants, biopsy 
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Fig. 1. DNA fragmentation in CF and control small intestine. DNA 
fragmentation (arrows) is detected in most of villous enterocytes of 
CF tissues (A) : the staining is evident in the nucleus of morphologi-
cally normal cells: some of them show a thin granular pattern in-
volving only a part of the nucleus (thin arrow), others show uni-
form and tense nuclear staining (arrow); some cells show features 
of shedding (arrowhead); stained bodies are present within the cyto-
plasm of some lamina propria mononuclear cells. Some villous en-
terocytes are devoid of any staining at the nuclear level (thin arrow-
head) (B). No staining was observed in non-CF control tissues (C). 
3 u. cryostat tissue sections: peroxidase staining technique (A-C). 
Original magnification: X110(A,C); X240 (B). 
specimens were embedded in OCT compound (Tissue Tek; Miles 
Laboratories, Elkhart, IN), snap-frozen in liquid nitrogen, and stored 
at — 70°C until cryosectioning. In two cases intestinal specimens were 
also fixed in formalin and embedded in paraffin according to routine 
histological procedures. Duodenal biopsies showed normal morphol-
ogy in all cases at routine histological examination. Gastric biopsies 
were obtained from three CF patients and three controls. 
2.3. Bronchial tissues 
Tissues from CF patients were formalin-fixed and paraffin-em-
bedded according to routine histological procedure. Immunohisto-
chemical analysis was performed in the peripheral part of the tissue, 
far from the atelectasic area; inflammatory findings were evident in 
peribronchial areas. 
Tissues from non-CF patients were collected far from the bronchial 
lesion; inflammatory findings were scattered in peribronchiolar areas, 
as in CF tissues. These specimens were embedded in paraffin accord-
ing to routine diagnostic procedure. 
2.4. In vitro tissue culture 
Duodenal biopsies from three CF patients (cases #6, #8 and #11, 
Table 1) and 10 controls were also cultured in vitro for 24 h. Mucosal 
samples from each patient were placed on a stainless steel mesh posi-
tioned over the central well of an organ culture dish, with the villus 
surface of the biopsy specimens uppermost. The cultures were made as 
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previously reported in the presence of the culture medium [10]. After 
incubation the specimens were harvested, snap-frozen in liquid nitro-
gen, and prepared for cryosectioning as described earlier. 
2.5. In situ detection of DNA fragmentation in epithelial cells 
Fresh intestinal specimens from all CF patients and controls were 
immersed in OCT compound, rapidly frozen in liquid nitrogen, and 
5 um sections were cut in a cryostat. Sections were air-dried and fixed 
in acetone. To detect cells with DNA fragmentation, we used terminal 
deoxynucleotidyl transferase (TdT)-mediated dUTP-digoxigenin nick-
end labelling (TUNEL) method as modified by Surh and Sprent [11]. 
DNA fragmentation was visualised by peroxidase or alkaline/phos-
phatase staining technique; both procedures gave the same results. 
In two intestinal samples cryostat and paraffin-embedded tissues, ac-
cording to Moss et al. [12], were simultaneously tested and the results 
compared afterwards. After validation of the TUNEL method on 
paraffin-embedded intestinal samples, paraffin-embedded lung sections 
were similarly analysed. 
2.5.1. Control experiments. For control of specificity we have 
used: (i) unfixed tissues compared with acetone-fixed tissues, to ex-
clude that DNA fragmentation observed in our study was due to 
manipulation after explants; (ii) incubation with TdT enzyme alone 
or with labelled nucleotides alone under the same experimental con-
ditions; (iii) incubation with TdT enzyme added with unlabelled nu-
cleotides; (iv) incubation of normal tissues with DNAse I (Sigma 
Chemical Co., 1 mg/ml for 15 min) under the same experimental 
conditions; (v) detection of the reaction product by two different 
technical approaches (peroxidase staining or alkaline phosphatase 
staining technique); (vi) processing of the biopsy samples in parallel 
with negative (control patients) and positive (atrophie coeliac biopsies, 
as well as DNAse treatment of normal biopsies) controls. All the 
experiments were performed at least 3 times each with the same re-
sults. 
2.5.2. Immunohistochemistry. Cryostat sections (3 urn) of each 
sample were incubated with the monoclonal antibody (mAb) anti-
Ki67 (Dako M722, working dilution, 1:25, Copenhagen, Denmark) 
as previously reported [10]. 
2.5.3. Morphometry and statistical analysis. At least five slides for 
each sample were evaluated. The number of dividing (Ki67+) cells in 
crypts was calculated for 100 crypt enterocytes. The number of cells 
with DNA fragmentation was calculated within the epithelial com-
partment on the villus as percentage of 100 enterocytes by counting 
at least 500 enterocytes in each sample. In lung tissues the number of 
epithelial cells with DNA fragmentation was expressed as percentage 
of total epithelial cells. The counts were performed at the microscope 
with a calibrated ocular graticule aligned parallel to the muscolaris 
Table 1 
Epithelial features of CF small intestine 
Patients 
1 
2 
3 
4 
5 
5a 
6 
7 
8 
9 
10b 
l l b 
12 
13 
14 
14e 
Age 
23 
8 
7 
15 
19 
11 
18 
14 
7 
4 
3 
15 
11 
4 
Sex 
M 
F 
M 
M 
M 
F 
M 
F 
F 
M 
F 
M 
M 
F 
Number of positive cells 
(per 100 enterocytes) 
Villous 
(DNA 
48 
30 
41 
51 
57 
54 
44 
71 
41 
35 
82 
52 
4 
23 
49 
51 
ragmentation) 
Crypts 
(Ki67) 
40 
42 
45 
37 
79 
71 
46 
24 
38 
51 
23 
34 
4 
16 
31 
35 
100! 
90 
80 
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a After 2 weeks of pancreatic enzyme withdrawal. 
bWithout pancreatic enzyme supplementation at the time of biopsy. 
cAfter 3 months of elemental diet. 
Fig. 2. Expression of DNA fragmentation in villus enterocytes and 
of Ki67 antigen in crypt enterocytes in CF and control subjects. 
Black bars, CF tissues (n=14); white bars, control tissues (« = 24). 
*P< 0.001 vs. controls. 
mucosae and independently analysed in a blind manner by two ob-
servers; the results were compared afterwards [10]. 
Student's two-tailed t test for independent samples was used to 
compare CF with control samples. Non-parametric tests (Wilcoxon 
two-tailed) also were applied and the results are concordant with 
those obtained using parametric tests. 
3. Results 
3.1. DNA fragmentation in villus enterocytes 
All the mucosal samples showed normal morphology; in all 
cases the villus height as well as the crypt depth were normal 
[13] and the villus height/crypt depth ratio was higher than 3. 
In mucosal samples from C F patients, the number of villus 
enterocytes showing D N A fragmentation was higher than in 
controls in all but one case (case #12, Table 1) (median: 46/ 
100 villus enterocytes; range: 4 -82 ; mean: 44.8, SD 19.2, vs. 
median: 3 ; range: 1-7; median: 2.95, SD 1.5 in controls; 
P< 0.0001) (Table 1 and Fig. 1A,B,C, Fig. 2). The cells that 
underwent D N A fragmentation were distributed along the 
villus at the top as well as in the medial region. Most of 
them appeared morphologically normal, with normal expres-
sion of brush border enzymes such as alkaline phosphatase 
and sucrase-isomaltase (not shown). Distinct patterns of 
staining, from a thin granular distribution involving only a 
part of the nucleus to a uniform and intense nuclear staining 
were observed in different cells (Fig. IB); other enterocytes 
showed, on the contrary, features of cellular shedding. Stained 
bodies were detected in the cytoplasm of lamina propria mac-
rophages located near to the surface epithelium (Fig. IB). 
These epithelial changes were also observed in those two 
patients (cases #10 and # 1 1 , Table 1) who underwent intesti-
nal biopsy in the absence of pancreatic enzyme supplementa-
tion, in patient # 5 (Table 1) after 2 weeks of pancreatic en-
zyme withdrawal, and in patient #14 (Table 1) after 3 months 
of elemental diet. 
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Fig. 3. DNA fragmentation in bronchial tissues of CF patients and non-CF controls. Most of epithelial cells in submucosal glands show DNA 
fragmentation in CF tissues (arrows) (A), whereas only scattered stained cells are found in non-CF controls (B). 3 um paraffin embedded tissue 
sections: peroxidase staining technique (A-B) (original magnification: X150 (A,B))-
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No differences in the pattern of DNA fragmentation were 
found between subjects with non-CF chronic pancreatitis and 
the other controls. 
3.1.1. Control experiments, (i) No differences were ob-
served between acetone-fixed and unfixed sections, (ii) No 
staining was detected after incubation of all CF tissues in 
the presence of TdT enzyme alone or with labelled nucleotide 
alone, (iii) No staining was detected after incubation with TdT 
enzyme added with unlabelled nucleotides. (iv) Strong staining 
of all the mucosal cells (both in lamina propria and epithelial 
compartment) was detected after incubation of control biop-
sies with DNAse. (v) No differences of staining were observed 
after detection of the reaction product with peroxidase or 
alkaline phosphatase staining technique, (vi) Differences be-
tween healthy controls and patient's tissues were always ob-
served even when the biopsies were processed at the same time 
and samples were studied simultaneously in the same experi-
ment. Moreover, concordant results were always obtained 
when tissue samples were repetitively studied. Finally identical 
results were obtained when we compared cryostat and paraf-
fin-embedded tissues from the same individual. 
3.1.2. Ki67 expression in crypt enterocytes. In all but one 
case (#12, Table 1) a very high number of crypt enterocytes 
showed Ki67 nuclear expression (median: 37.5/100 crypt en-
terocytes; range: 4—79; mean: 36.4, SD 17.7, vs. median: 5; 
range: 1-8; mean: 4.7, SD 1.9 in controls; P< 0.0001) (Table 
1 and Fig. 2). Ki67+ enterocytes were restricted to the crypt 
region. 
3.1.3. In vitro tissue culture of intestinal expiants. In the 
three patients in whom tissue culture was performed for 24 h 
in the presence of the medium alone, the number of cells with 
DNA fragmentation was unchanged with respect to that 
found before culture (case #6, before culture 44/100 villus 
enterocytes and after culture 42/100; case #8, 41/100 and 
44/100, respectively; case #11, 52/100 and 58/100, respec-
tively); similarly a high number of dividing cells was observed 
in crypts (case #6, before culture 46/100 crypt enterocytes and 
after culture 49/100; case #8, 38/100 and 45/100, respectively; 
case #11, 34/100 and 37/100, respectively). Similarly, in 10 
control samples, a period of 24 h of in vitro culture did not 
alter the pattern of epithelial DNA fragmentation or Ki67 
expression observed prior in vitro manipulation (DNA frag-
mentation in villus enterocytes; median: 2.6; range: 1-6; 
mean: 2.4, SD 1.1; _P = NS vs. samples before culture; Ki67 
expression in crypts; median: 5.1; range: 2-7; mean: 5.6, SD 
1.8; P = NS vs. samples before culture). 
3.1.4. DNA fragmentation in gastric epithelium. In three 
CF patients (cases #4, #6 and #9, Table 1) in whom gastric 
biopsies were also performed, high epithelial DNA fragmen-
tation was also observed (case #4, 21/100 epithelial cells; case 
#6, 18/100 epithelial cells; case #9, 22/100 epithelial cells, vs. 
controls 2/100, 4/100 and 7/100, respectively). 
3.1.5. DNA fragmentation in bronchial tissue. In the lower 
respiratory tract, 57% (range : 54-70) of epithelial cells showed 
DNA fragmentation; a high number of such cells was found 
in submucosal glands, both in collecting ducts where the stain-
ing was prominent in the basal epithelium (Fig. 3A) and in 
serous and mucous tubuli. Conversely, in non-CF bronchial 
tissue we observed only a few cells with DNA fragmentation 
(5%; range: 3-7) (Fig. 3B). A similar phenomenon was ob-
served in airway surface epithelium with more than 35% 
(range : 30-40) of epithelial cells showing DNA fragmentation 
in CF patients (data not shown) whereas in controls less than 
5%> (range: 2-8) of epithelial cells were stained. 
4. Discussion 
We have shown that high DNA fragmentation, and likely 
apoptosis, is a feature of various epithelia in CF. 
CF is a disease caused by the altered function of CFTR 
mutated gene. The CFTR protein has a central role in con-
trolling the electrolyte transport across the epithelia. How-
ever, it has been demonstrated that CFTR may also control 
apoptosis of epithelial cells [9] and it has been hypothesised 
that DNA fragmentation and therefore apoptosis may be al-
tered in CF [9]. Apoptosis, or programmed cell death, is a 
mechanism regulating cell function and its pivotal role in 
the development and maintenance of higher organisms, in-
cluding humans, is commonly accepted [14,15]. It occurs as 
a result of the activation of a highly defined and well-con-
trolled pathway [16], and is characterised by nuclear changes 
such as chromatin condensation, fragmentation and margin-
ation, as well as internucleosomal DNA cleavage. DNA frag-
mentation is commonly considered as the key feature of apop-
tosis in many cell types and different techniques, including 
TUNEL [17], have been used to detect apoptosis. TUNEL 
has been widely accepted as a technique able to detect apop-
tosis [11] although it only detects DNA fragmentation, a key 
event of the apoptosis/programmed cell death process. Several 
reports indicate the fundamental importance of apoptosis in 
the maintenance of normal function in the gut, and that ab-
normalities of apoptosis potentially contribute to gastrointes-
tinal diseases [14,18-20]. By using the TUNEL technique, it 
has been reported that in the small intestine of human and 
rodents apoptosis at the luminal surface controls the fate of 
most enterocytes. However, apoptosis is a very rapid process 
and in normal steady-state conditions it is likely that the ma-
jority of enterocytes that underwent cellular death would be 
rapidly cleared and no longer recognisable. Recently, the TU-
NEL technique has been used to detect apoptosis in intestinal 
epithelial cells of coeliac disease (CD) patients [12]. By this 
approach Moss et al. [12] demonstrated that in the atrophie 
CD small intestine higher apoptosis occurs in surface epithe-
lium as well as in crypt epithelial cells, compared to that 
observed in morphologically normal treated CD intestine. In 
this paper we have demonstrated, by using the same technique 
(TUNEL), that inappropriately high DNA fragmentation oc-
curs in morphologically normal CF epithelia. This pattern is 
observed in all but one CF case, irrespective of the nutritional 
status and the genotype of the patients. In the CF small in-
testine a high number of villus enterocytes show DNA frag-
mentation; some of them present normal morphology with 
normal expression of brush border enzymes, some others 
show features of cellular shedding. Moreover, stained bodies 
are also present in lamina propria macrophages. These stained 
bodies are absent in control tissues, and they likely represent a 
late event of the cell death pathway. 
DNA fragmentation observed in our studies was not due to 
the in vitro manipulation, as the samples were processed im-
mediately after expiants. Increased DNA fragmentation does 
not seem to be caused by an ongoing inflammatory process in 
duodenal mucosa, such as we have observed in many CF 
individuals (unpublished data). Indeed we have found in-
creased DNA fragmentation in villus enterocytes even in those 
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cases in which no signs of inflammation in the small intestine 
were observed. Finally the phenomena detected in CF epithe-
lial cells are not related to endoluminal factors since (i) they 
are still present in a patient after 3 months of elemental diet 
and (ii) they are observed even in patients who were not 
treated with pancreatic enzyme supplementation. Moreover, 
high DNA fragmentation was also observed in villus enter-
ocytes after in vitro organ culture of duodenal expiants, in-
dicating that these features are likely not related to environ-
mental factors, but intrinsic to the intestinal mucosa itself. 
DNA fragmentation is confined to the villus area, since no 
staining was observed in crypt epithelial cells. Most of the 
latter cells show, on the contrary, high expression of the 
Ki67 antigen, thus suggesting that many crypt enterocytes 
are dividing. 
Increased DNA fragmentation is not exclusive to small in-
testinal epithelial cells, but also occurs in other gastrointesti-
nal epithelia, as in the stomach. Moreover, it is also evident in 
the submucosal glands of the respiratory tract. Inappropriate 
DNA fragmentation is therefore a key feature of CF since it is 
observed in several epithelia in vivo. 
Excessive DNA fragmentation may be related, in an un-
known fashion, to the lack of wild-type CFTR protein in 
epithelial cells. Two considerations point in this direction. 
First, in airways DNA fragmentation is chiefly observed at 
the sites of maximal expression of CFTR (submucosal glands) 
[21]. Second, this phenomenon is less evident in the stomach, 
where the expression of CFTR is less marked [22]. That the 
CFTR may play a role in the process of apoptosis has been 
recently described [9]. This report demonstrated that the 
CFTR may be involved in the initiation of apoptosis by en-
hancing the acidification in the epithelial cell milieu [9]. Acid-
ification has been proved to be involved in apoptosis mediated 
by Fas ligation, cycloheximide, or ultraviolet radiation [23]. A 
resistance to the induction of apoptosis mediated by these 
factors was in fact observed in CFTR-mutated transfected 
cells. Our results in vivo indicate that DNA fragmentation 
is increased in CF epithelia. One possible interpretation of 
this apparent discrepancy is that in CF patients DNA is in-
appropriately nicked in fragments of variable size, but final 
degradation by endonucleases does not occur, or other apop-
tosis related processes fail to occur. This would indicate a 
situation in which the apoptotic process is initiated, but 
then aborted. That the apoptotic process is interrupted is in-
dicated by the normal morphology of villus enterocytes, de-
spite DNA fragmentation. Moreover, a smaller number of 
cells with features of shedding was seen than would have 
been expected on the basis of the high number of cells with 
DNA fragmentation. The role of CFTR in this process may 
therefore consist of an inhibitory effect by determining an 
inability to reach the end-point, cellular death, or by causing 
delay in the apoptotic pathways. It is also unknown what is 
the primary event responsible for the high DNA fragmenta-
tion. The involvement of a yet unknown other gene respon-
sible for this phenomenon might be a suggestive hypothesis, 
and it might also explain the lack of correlation genotype/ 
phenotype observed in CF patients (with the exception of 
pancreatic insufficiency) and in transgenic animals [24]. Exper-
imental on transgenic mice may contribute to clarify these 
phenomena. 
On the other hand it could be supposed that in CF the 
villus cell death is rapidly compensated by the increased pro-
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liferation in crypts. The normal mucosal architecture results 
from the balance of proliferation, migration, differentiation 
and death along the crypt-villus axis. If high cell death on 
the villus is compensated by the replication and migration 
of crypt enterocytes, a balance is achieved without villus dam-
age and with normal mucosal architecture. In normal condi-
tions there is a 'low-level' balance; in CF patients it may be 
possible that this balance is achieved at 'higher level', with 
high cell death in the villus enterocytes and high proliferation 
in crypts leading to normal villus morphology. 
These two different interpretations, excessive DNA frag-
mentation with a defect (or delay) in cell death, or increased 
cell death with high cellular turnover, might also be related to 
each other. In fact the same keys of the signalling pathways of 
the apoptotic machinery may operate in a different way in 
different cells (villus or crypt enterocytes) in relation to differ-
ent phases of the cell cycle [16]. 
We indeed do not know whether in CF we are dealing with 
a condition of excessive apoptosis or, on the contrary, we are 
observing a condition of aborted apoptosis. 
Whatever the mechanism, these results demonstrate that a 
perturbation in the cell death pathway is a feature of CF 
epithelial cells. Inappropriate apoptosis contributes to the 
pathology of several human diseases [25-29]. Insufficient 
apoptosis is associated with many cancers that are now be-
lieved to be a consequence of failed apoptotic cell death [26] ; 
in addition flawed apoptosis is a feature of autoimmune dis-
orders [27]. On the contrary disorders of excessive apoptosis 
have been described, as in Alzheimer's disease, in which hip-
pocampal neurons appear to prematurely commit suicide with 
consequent neurological damage [28], or in spinal muscolar 
atrophy, in which the loss of motor neurons in the spinal 
cord has been linked to a defect in a gene that encodes neuro-
nal apoptosis inhibitory protein [29]. If also CF epithelial cells 
are characterised by inappropriate regulation of the apoptotic 
machinery it is likely that the many pathological features of 
CF might be related to the impaired regulation of the cell 
death pathways. 
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